Product Information
CLIND PH-BENZOYL PERO 1.2-2.5% is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.8191 per GM under NDC 51672136703. Its NADAC has been published 363 times since Oct 23, 2019.
FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 10 mg/g; mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672136703
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA206575FDA Approved
8/19/2019
TE Code
AB
On Market Since
8/19/2019
Pharmacological Classes
Price Statistics
The NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has been published 363 times since Oct 23, 2019, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8191 per GM |
|---|---|
| All-time high | $7.4004 (Mar 11, 2020) |
| All-time low | $0.6671 (Jul 22, 2026) |
| 52-week high | $0.9869 |
| 52-week low | $0.6671 |
| Median price | $1.2923 |
| Average price | $1.6843 |
| Largest weekly change | +71.0% (Feb 22, 2023) |
| Weeks tracked | 363 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLIND PH-BENZOYL PERO 1.2-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PERO 1.2-2.5%, manufactured by Sun Pharmaceutical Industries Inc., is $0.8191 per GM (NDC 51672136703), effective Sep 30, 2026.
How has the price of CLIND PH-BENZOYL PERO 1.2-2.5% changed over time?
Over the history we have for it, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has declined 88.9%. It has been tracked across 363 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PERO 1.2-2.5%?
Since Oct 23, 2019, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has ranged from a low of $0.6671 (Jul 22, 2026) to a high of $7.4004 (Mar 11, 2020), with a median of $1.2923 per GM.
Are there cheaper alternatives to CLIND PH-BENZOYL PERO 1.2-2.5%?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLIND PH-BENZOYL PERO 1.2-2.5% in a comparable dosage form, but none are currently priced below it.
Who manufactures CLIND PH-BENZOYL PERO 1.2-2.5%?
CLIND PH-BENZOYL PERO 1.2-2.5% (NDC 51672136703) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.